Why Do Bronchitis Patients Develop Low-Grade Fever?
Low-grade fever in patients with bronchitis is a common clinical finding and typically reflects the body’s immune response to airway inflammation. Bronchitis—whether acute or chronic—often stems from
Low-grade fever in patients with bronchitis is a common clinical finding and typically reflects the body’s immune response to airway inflammation. Bronchitis—whether acute or chronic—often stems from viral infections, such as rhinovirus, influenza, or respiratory syncytial virus (RSV), though bacterial pathogens like *Mycoplasma pneumoniae* or *Bordetella pertussis* may also contribute, particularly in atypical or prolonged cases.
In acute bronchitis, low-grade fever (generally defined as temperatures between 37.5°C and 38.3°C or 99.5°F to 100.9°F) arises from cytokine-mediated inflammation in the bronchial mucosa. This localized immune activation increases prostaglandin E2 synthesis in the hypothalamus, resetting the body’s thermoregulatory set point. Importantly, fever is usually mild and transient—lasting no more than 3–4 days—and rarely exceeds 38.5°C (101.3°F). Its presence does not necessarily indicate bacterial superinfection; most cases remain viral and self-limiting.
In contrast, persistent or recurrent low-grade fever in individuals with chronic bronchitis—especially those with underlying COPD or structural lung disease—may signal complications such as acute exacerbation, colonization with resistant organisms (e.g., *Pseudomonas aeruginosa*), or comorbid conditions including bronchiectasis, gastroesophageal reflux disease (GERD), or early-stage interstitial lung disease. Clinicians should assess for associated red flags: worsening dyspnea, increased sputum volume or purulence, hemoptysis, weight loss, or night sweats.
Management focuses on supportive care—hydration, antipyretics if symptomatic, and avoidance of unnecessary antibiotics—while reserving targeted antimicrobial therapy only when objective evidence of bacterial infection emerges (e.g., elevated procalcitonin, positive sputum culture with clinical correlation). Vigilant monitoring remains essential, as prolonged subfebrile temperatures warrant further evaluation to exclude non-infectious etiologies such as sarcoidosis or malignancy.